The University of Kansas Medical Center and Children’s Mercy Hospital have halted a clinical trial of a COVID-19 vaccine after a participant in the United Kingdom developed an adverse reaction.
Pharmaceutical company AstraZeneca, which developed the vaccine along with the University of Oxford, said on Tuesday that it had put Phase 3 testing of the vaccine on hold while it conducts a safety review o…